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cLETTER TO THE EDITOR
Pericardial effusion and sepsis
caused by Staphylococcus schleiferi
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Dear editor,
A 55-year-old man presented with a one-week
history of worsening retrosternal chest pain, associ-
ated with palpitations and chills. He had a non-life
threatening penicillin allergy. He was tachycardic,
tachypneic, normotensive, and afebrile. Decreased
bilateral air entry to lung bases and irregular
distant heart sounds were noticed on auscultation.
Electrocardiogram showed atrial ﬁbrillation. Hema-
tological investigations were signiﬁcant for a white
blood cell count of 23,700 cells/mcL with 80.6%
neutrophils. A chest CT-scan revealed bilateral
pleural effusions and a large pericardial effu-
sion. Empiric antibiotic therapy with vancomycin
and aztreonam was started. Transesophageal-
echocardiogram did not show any vegetations. A
pericardial window was performed and the ﬂuid
was sent for gram and acid-fast stains and cultures.
Gram-positive cocci in clusters were identiﬁed on
gram stain with a positive coagulase test. Peri-
cardial ﬂuid and blood cultures became positive
with Staphylococcus schleiferi. The organism had
antibiotic susceptibility to oxacillin, cefoxitin,
trimethoprim-sulfamethoxazole, erythromycin,
ciproﬂoxacin, daptomycin, linezolid, gentamicin,
doxycycline, tetracycline, vancomycin, rifampin,
and clindamycin with a negative D-zone test.
The antibiotics were switched to cefazolin and
continued for two uneventful weeks. Repeat blood
cultures at 72 h were negative. Follow-up echocar-
diogram showed a signiﬁcant decrease in the
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n oral doxycycline for seven days.
Staphylococcus schleiferi subsp. schleiferi,
amed in honor of the German microbiologist
arl Heinz Schleifer, was ﬁrst reported in 1988 by
reney et al. as a new coagulase-negative species
fter its isolation from human specimens. It was
usceptible to novobiocin, produced a heat-stable
uclease and a ﬁbrinogen afﬁnity factor, and failed
o produce coagulase and staphylokinase. It dif-
ered from Staphylococcus aureus by its production
f an antigenically different heat-stable nuclease
nd its lack of pigmentation, free coagulase,
rotein A, and Q-ribitol teichoic acid [1]. Following
ts description, subsp. schleiferi, was implicated
n many human infections and isolated from ear
xudates, cerebrospinal ﬂuid, pleural ﬂuid, corneal
xudates, biliary drainage [3], blood, orthopedic
mplants [4], brain abscesses [5], pacemakers and
ther devices [5,6], urine [7], and wounds [6].
Later, in 1990, a coagulase-positive species, S.
chleiferi subsp. coagulans, was reported by Igimi
t al. in dogs with external otitis. It was distin-
uished from subsp. schleiferi by its coagulase test
eaction and from the other coagulase-negative
pecies by its production of coagulase, heat-stable
uclease, and p-hemolysin. It was further distin-
uished from other coagulase-positive species by
ts acetoin and p-hemolysin production, negative
yaluronidase activity, and lack of acid production
rom trehalose or maltose [2]. Human infection
ith subsp. coagulans was reported three times in
he literature, with isolates from surgical wound
nfection [8], blood, ascitic ﬂuid, synovial ﬂuid [9],
nd a left ventricular assist device [10].
To our knowledge, this is the ﬁrst report of peri-
ardial effusion secondary to S. schleiferi. This
ase expands the spectrum of S. schleiferi as a
ause of human infections and emphasizes the
mportance of recognizing other coagulase-positive
acteria, without relying on the coagulase test for
he deﬁnitive diagnosis of S. aureus. Furthermore,
nces. Published by Elsevier Limited. All rights reserved.
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his species is commonly observed in canines; thus,
thorough history of animal contact is warranted.
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